Analgesic Efficacy of Saphenous Nerve Blockade for Outpatient Knee Anterior Cruciate Ligament Surgery
NCT ID: NCT02071433
Last Updated: 2017-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
58 participants
INTERVENTIONAL
2014-03-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obturator Nerve Block With Femoral and Sciatic Block
NCT01409460
Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block
NCT02548104
Tibial Nerve Versus Sciatic Nerve Block
NCT01415193
Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia
NCT02387021
Adductor Canal Block In Anterior Cruciate Ligament (ACL) Repair
NCT01791036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Saphenous nerve blockade
Experimental treatment 15 mL of levobupivacaine 0.5%
Saphenous nerve blockade
Femoral nerve blockade
Standard treatment 15 mL of levobupivacaine 0.5%
Femoral nerve blockade
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Saphenous nerve blockade
Femoral nerve blockade
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA status I - III
* rupture of the anterior cruciate ligament.
Exclusion Criteria
* allergy against local anesthetics
* BMI \> 35
* pre-existing diagnosed neuropathy of the operated leg
* ingestion of strong opioids
* pregnancy or breastfeeding status
* History of significant cardiovascular disease (MI, CVA, peripheral vascular disease)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
W ten Hoope
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Academic Medical Centre Amsterdam
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACLS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.